{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:32:39Z","timestamp":1792071159799,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaut.2019.102337","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T07:17:25Z","timestamp":1570259845000},"page":"102337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers"],"prefix":"10.1016","volume":"106","author":[{"given":"Claire MJ.","family":"Lefeuvre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9 A.","family":"Payet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odessa-Maud","family":"Fayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bondet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"de Montpreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Rosa","family":"Ghigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mansuet-Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Validire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Gossot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Behin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102337_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"A comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102337_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10238-008-0158-y","article-title":"Myasthenia gravis and the thymus gland. A historical review","volume":"8","author":"Raica","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2019.102337_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00595-012-0318-2","article-title":"Thymus, thymoma and myasthenia gravis","volume":"43","author":"Fujii","year":"2013","journal-title":"Surg. Today"},{"key":"10.1016\/j.jaut.2019.102337_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00415-006-0429-z","article-title":"Paraneoplastic diseases associated with thymoma","volume":"254","author":"Evoli","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2019.102337_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic syndromes and thymic malignancies: an examination of the international thymic malignancy interest group retrospective database","volume":"13","author":"Padda","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jaut.2019.102337_bib7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in patients with MG: characteristics and long-term outcome","volume":"59","author":"Evoli","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.102337_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.athoracsur.2009.08.074","article-title":"Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery","volume":"89","author":"Margaritora","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jaut.2019.102337_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.102337_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0003-4975(91)90478-9","article-title":"Thymoma: results of 241 operated cases","volume":"51","author":"Maggi","year":"1991","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jaut.2019.102337_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jneuroim.2008.07.012","article-title":"Thymoma-associated myasthenia gravis: outcome, clinical and pathological correlations in 197 patients on a 20-year experience","volume":"201\u2013202","author":"Maggi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.102337_bib13","doi-asserted-by":"crossref","first-page":"73774","DOI":"10.18632\/oncotarget.17908","article-title":"Significance of B10 cell in patients with thymoma complicated with myasthenia gravis","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2019.102337_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.athoracsur.2008.04.070","article-title":"Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody","volume":"86","author":"Nakajima","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jaut.2019.102337_bib15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.athoracsur.2014.10.068","article-title":"Risk factors for developing postthymectomy myasthenia gravis in thymoma patients","volume":"99","author":"Yamada","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jaut.2019.102337_bib16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/ejcts\/ezv380","article-title":"Myasthenia gravis with thymic epithelial tumour: a retrospective analysis of a Japanese database","volume":"49","author":"Nakajima","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.jaut.2019.102337_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0009-8981(91)90371-I","article-title":"Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis","volume":"201","author":"Ohta","year":"1991","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2019.102337_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00005792-197809000-00002","article-title":"Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy","volume":"57","author":"Namba","year":"1978","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2019.102337_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejcts.2005.03.039","article-title":"Myasthenia gravis appearing after thymectomy for thymoma","volume":"28","author":"Kondo","year":"2005","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"1","key":"10.1016\/j.jaut.2019.102337_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2019.102337_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2302\/kjm.20.69","article-title":"Thymoma and thymic germinal center","volume":"20","author":"Watanabe","year":"1971","journal-title":"Keio J. Med."},{"key":"10.1016\/j.jaut.2019.102337_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0003-4975(10)62185-6","article-title":"Myasthenia gravis with thymoma: analysis of and postoperative prognosis for 65 patients with thymomatous myasthenia gravis","volume":"38","author":"Monden","year":"1984","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jaut.2019.102337_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02899268","article-title":"B-cells in thymic epithelial tumours. An immunohistochemical analysis of intra- and extraepithelial B-cell compartments","volume":"63","author":"Fend","year":"1993","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1016\/j.jaut.2019.102337_bib24","first-page":"61","article-title":"B cells in thymomas","volume":"3","author":"Kornstein","year":"1990","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jaut.2019.102337_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.21037\/jtd.2016.03.03","article-title":"Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma","volume":"8","author":"Song","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jaut.2019.102337_bib26","doi-asserted-by":"crossref","first-page":"95432","DOI":"10.18632\/oncotarget.20731","article-title":"Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?","volume":"8","author":"Cavalcante","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2019.102337_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2019.102337_bib28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.102337_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102337_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","article-title":"Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling","volume":"179","author":"Coppola","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2019.102337_bib31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2019.102337_bib32","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/JTO.0b013e3182217bec","article-title":"The Association of Intratumoral Germinal Centers with early-stage non-small cell lung cancer","volume":"6","author":"Gottlin","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jaut.2019.102337_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2019.102337_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.59.1.92","article-title":"The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970-1999","volume":"59","author":"Somnier","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.102337_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: on the search for a pathogen signature","volume":"52","author":"Cufi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102337_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102337_bib38","doi-asserted-by":"crossref","first-page":"25886","DOI":"10.1038\/srep25886","article-title":"Changes in inflammatory cytokine networks in myasthenia gravis","volume":"6","author":"Uzawa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102337_bib39","article-title":"CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines","volume":"97","author":"Fang","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2019.102337_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cyto.2014.10.014","article-title":"Interferon gamma in autoimmunity: a complicated player on a complex stage","volume":"74","author":"Lees","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2019.102337_bib41","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib43","doi-asserted-by":"crossref","first-page":"194864","DOI":"10.1155\/2015\/194864","article-title":"Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives","volume":"2015","author":"Lopalco","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2019.102337_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/1521-4141(200101)31:1<225::AID-IMMU225>3.0.CO;2-0","article-title":"Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis","volume":"31","author":"Huang","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082155","article-title":"Interleukin-1 beta-A friend or foe in malignancies?","volume":"19","author":"Bent","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2019.102337_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2019.102337_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1189\/jlb.1104669","article-title":"Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation","volume":"78","author":"Elzey","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2019.102337_bib48","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4","volume":"166","author":"Im","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102337_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","article-title":"Paraneoplastic myasthenia gravis: immunological and clinical aspects","volume":"15","author":"Skeie","year":"2008","journal-title":"Eur. J. Neurol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119305281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119305281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:14Z","timestamp":1760257394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119305281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"alternative-id":["S0896841119305281"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102337","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102337"}}